Concepedia

Lauric Haber

LH

11

Publications

1.3K

Citations

11

H-Index

2005

Active since

Affiliations

Regeneron (United States)(Current)

Lauric Haber is an author at Regeneron (United States) specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2005–2022

11

Publications

11

A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies

Gabriele Schaefer, Lauric Haber, Lisa Crocker et al. · Cancer Cell · 2011 · 332 citations · Full text

, , +9

A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys

Eric Smith, Kara Olson, Lauric Haber et al. · Scientific Reports · 2015 · 160 citations · Full text

A general method for greatly improving the affinity of antibodies by using combinatorial libraries

Arvind Rajpal, Nurten Beyaz, Lauric Haber et al. · Proceedings of the National Academy of Sciences · 2005 · 151 citations · Full text

A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies

Dimitris Skokos, Janelle Waite, Lauric Haber et al. · Science Translational Medicine · 2020 · 141 citations

A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer

Alison Crawford, Lauric Haber, Marcus P. Kelly et al. · Science Translational Medicine · 2019 · 137 citations · Full text

Rows per page

1–5 of 11